Ketamine modulates hippocampal neurogenesis and pro-inflammatory cytokines but not stressor induced neurochemical changes
Authors:
- 1 January 2017
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 112, 210-220
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 57 references indexed in Scilit:
- Signaling pathways underlying the rapid antidepressant actions of ketamineNeuropharmacology, 2012
- Ketamine as a Novel Antidepressant: From Synapse to BehaviorClinical Pharmacology & Therapeutics, 2011
- Effects of Ketamine on Endotoxin and Traumatic Brain Injury Induced Cytokine Production in the RatJournal of Trauma: Injury, Infection & Critical Care, 2011
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress ExposureBiological Psychiatry, 2011
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Oral Ketamine for the Rapid Treatment of Depression and Anxiety in Patients Receiving Hospice CareJournal of Palliative Medicine, 2010
- Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behaviorProceedings of the National Academy of Sciences, 2010
- Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate AntagonistBiological Psychiatry, 2009
- Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant ReversalBiological Psychiatry, 2008
- Twenty years of research on cytokine-induced sickness behaviorBrain, Behavior, and Immunity, 2007